[Second look operation from the current viewpoint].

H Janisch

Home/Archive/PubMed

PubMed · 2098283

[Second look operation from the current viewpoint].

H Janisch

View original source ↗Export metadata ↓

Abstract

Tumor reduction or elimination during primary surgery is the most important goal to aim at. Platinum-containing poly-chemotherapies led to an increase in remissions. However, highly advanced technologies (computed tomography, ultrasonography, nuclear magnetic resonance) and combined analysis of tumor markers are not sensitive enough to evaluate tumor-free status. A false-positive rate up to 33% at the time of second-look surgery was assessed in patients in clinical complete remission. Therapeutic second-look surgery with the purpose of tumor reduction is not capable to prolong the patient's survival time. Therefore, second-look surgery is limited to a diagnostic procedure, resulting in an objective assessment of newly developed therapy strategies.

Explore related subjects

Combined Modality Therapy Female Follow-Up Studies Humans Ovarian Neoplasms Postoperative Complications Reoperation Survival Rate English Abstract Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

H Janisch. 1990. [Second look operation from the current viewpoint].. https://pubmed.ncbi.nlm.nih.gov/2098283/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

[Effectiveness of Integrated Psychological Therapy for schizophrenia patients. A meta-analysis including 28 independent studies].

Over the past 24 years, research groups in eight different countries have conducted 28 independent evaluation studies on Integrated Psychological Therapy (IPT) including 1,329 schizophrenia patients. The present study examines the effectiveness of IPT under different treatment conditions by means of a meta-analytic review. The most salient results indicate favourable mean effect sizes for IPT in comparison to control groups (placebo-attention conditions, standard care). Moreover, the superiority of IPT continues to increase during an average catamnestic phase of 8.1 months. The method obtains similarly favourable effects in different functional areas (neurocognition, social behaviour, psychopathology) and different assessment formats (expert ratings, self-reports, psychological tests). The comparison of different settings of IPT and control groups shows the superiority of IPT in any given therapy or site condition. The analysis of subsamples of inpatients, outpatients, and patients in varying rehabilitation phases reveals similarly favourable effects. Comparing only high-quality studies yields comparable results. In summary, the present meta-analysis corroborates evidence that IPT is an 'empirically validated treatment' according to American Psychiatric Association guidelines.

Combined Modality Therapy↗

PubMed2006

Successful treatment of MYCN amplified, progressive stage 4S neuroblastoma in a neonate with hepatic artery embolization in addition to multimodality treatment.

Stage 4S metastatic neuroblastoma (NB) has a favorable prognosis due to a high rate of spontaneous regression. Young infants risk lethal complications arising from hepatomegaly, which can develop rapidly despite treatment. MYCN oncogene amplification confers a significantly worse prognosis. We describe a 4-week-old neonate with MYCN-amplified stage 4S NB complicated by gross hepatomegaly causing rapidly progressive respiratory, hepatic, and renal failure. The child remains in remission 3 years after hepatic artery embolization, radiotherapy, standard, and high-dose chemotherapy. Embolization of the hepatic artery, with classical treatment, is feasible and safe at this age and may contribute substantially to the management of high-risk patients.

Combined Modality Therapy↗

PubMed2006

[Leiomyosarcoma of the larynx].

Leiomyosarcoma is usually found in the female genital tract, retroperitoneum, the wall of the gastrointestinal tract and subcutaneous tissues. An appearance of this malignant tumor in the larynx is extremely rare and may be difficult to diagnose. Because of its rarity, little information exists on management and prognosis. We report on a 64-year old male with a supraglottic leiomyosarcoma who was treated with supraglottic laryngectomy and postoperative radiotherapy. After 19 months the patient was well and free of disease. The most commonly used diagnostic and therapeutic procedures are analysed in a review of the 46 published cases of laryngeal leiomyosarcoma.

Combined Modality Therapy↗